Core Laboratories N.V. (CLB)

Core Laboratories Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	511.07	509.79	489.74	470.25	487.27	668.21
Revenue Growth (YoY)	1.65%	4.10%	4.14%	-3.49%	-27.08%	-4.66%
Cost of Revenue	403.02	399.96	393.66	367.9	374.77	495.58
Gross Profit	108.05	109.83	96.08	102.36	112.5	172.63
Selling, General & Admin	35.72	40.26	38.12	44.17	34.03	48.02
Other Operating Expenses	15.61	14.93	16.44	12.92	155.27	27.92
Operating Expenses	51.32	55.19	54.56	57.09	189.31	75.95
Operating Income	56.73	54.64	41.52	45.26	-76.81	96.68
Interest Expense / Income	13.42	13.43	11.57	9.15	14.37	14.69
Other Expense / Income	0.55	0.35	0.21	0.49	0.56	-7.7
Pretax Income	42.76	40.86	29.75	35.62	-91.74	89.69
Income Tax	5.23	4.19	10.3	15.89	5.9	-12.29
Net Income	37.52	36.68	19.45	19.73	-97.64	101.98
Net Income Growth	58.23%	88.53%	-1.39%	-	-	28.24%
Shares Outstanding (Basic)	47	47	46	46	44	44
Shares Outstanding (Diluted)	48	48	47	47	44	45
Shares Change	0.47%	1.52%	0.26%	4.98%	-0.38%	0.39%
EPS (Basic)	0.81	0.79	0.42	0.44	-2.20	2.30
EPS (Diluted)	0.80	0.78	0.42	0.43	-2.20	2.28
EPS Growth	56.86%	85.71%	-2.33%	-	-	27.37%
Free Cash Flow	23.04	14.76	16.6	23.4	47.22	67.97
Free Cash Flow Per Share	0.49	0.32	0.36	0.51	1.06	1.53
Dividend Per Share	0.040	0.040	0.040	0.040	0.280	2.200
Dividend Growth	0%	0%	0%	-85.71%	-87.27%	0%
Gross Margin	21.14%	21.54%	19.62%	21.77%	23.09%	25.83%
Operating Margin	11.10%	10.72%	8.48%	9.63%	-15.76%	14.47%
Profit Margin	7.34%	7.19%	3.97%	4.19%	-20.04%	15.26%
Free Cash Flow Margin	4.51%	2.90%	3.39%	4.98%	9.69%	10.17%
Effective Tax Rate	12.24%	10.24%	34.61%	44.62%	-	-13.70%
EBITDA	71.76	70.07	58.48	63.29	-56.5	126.99
EBITDA Margin	14.04%	13.75%	11.94%	13.46%	-11.60%	19.00%
Depreciation & Amortization	15.58	15.78	17.16	18.52	20.87	22.61
EBIT	56.18	54.29	41.32	44.77	-77.37	104.38
EBIT Margin	10.99%	10.65%	8.44%	9.52%	-15.88%	15.62%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).